Balance Sheet TME Pharma N.V.

Equities

ALTME

NL0015000YE1

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 12:55:00 2026-03-10 pm EDT			5-day change	1st Jan Change
0.0763 ^EUR	+2.83%		+5.83%	+17.02%

Mar. 09	TME Pharma Secures 12-month Loan Extension	MT
Jan. 05	TME Pharma N.V. Provides Update on Its Activities	CI

91f03.REbMsWARDLnR70jJWFiHqqnugi1nGjfadTX4Uzzyn88.Ly2AhAF-do3jviuWNBq0h_i65ncCYm2sBW-SEHWG1qAPEKHlFHhNyJSwHQ

Published financial data: TME PHARMA N.V.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	-	-	-	-	-
Other Revenues, Total	35K	33K	-	-	-
Total Revenues	35K	33K	-	-	-
Cost of Goods Sold, Total	-	-	-	-	-
Gross Profit	35K	33K	-	-	-
Selling General & Admin Expenses, Total	1.88M	2.88M	3.88M	2.99M	2.98M
R&D Expenses	4.02M	10.66M	8.15M	2.65M	2.3M
Other Operating Expenses	-39K	-39K	-16K	-17K	-19K
Other Operating Expenses, Total	5.86M	13.49M	12.01M	5.62M	5.26M
Operating Income	-5.82M	-13.46M	-12.01M	-5.62M	-5.26M
Interest Expense, Total	-3K	-49K	-133K	-17K	-18K
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-3K	-49K	-133K	-17K	-18K
Currency Exchange Gains (Loss)	12K	184K	-33K	9K	7K
Other Non Operating Income (Expenses)	-5.04M	-1.42M	-3.27M	-1.34M	-453K
EBT, Excl. Unusual Items	-10.86M	-14.74M	-15.45M	-6.97M	-5.72M
Restructuring Charges	-	-	-	-	-
Asset Writedown	-	-	-	-	-
Other Unusual Items	449K	291K	321K	237K	-
EBT, Incl. Unusual Items	-10.41M	-14.45M	-15.13M	-6.73M	-5.72M
Income Tax Expense	-	1K	7K	2K	-
Earnings From Continuing Operations	-10.41M	-14.45M	-15.13M	-6.74M	-5.72M
Net Income to Company	-10.41M	-14.45M	-15.13M	-6.74M	-5.72M
Minority Interest	1K	1K	1K	-	-
Net Income - (IS)	-10.4M	-14.45M	-15.13M	-6.74M	-5.72M
Net Income to Common Incl Extra Items	-10.4M	-14.45M	-15.13M	-6.74M	-5.72M
Net Income to Common Excl. Extra Items	-10.4M	-14.45M	-15.13M	-6.74M	-5.72M
Per Share Items
Net EPS - Basic	-32.16	-21.9	-12.86	-1.34	-0.16
Basic EPS - Continuing Operations	-32.16	-21.9	-12.86	-1.34	-0.16
Basic Weighted Average Shares Outstanding	324K	660K	1.18M	5.02M	35.98M
Net EPS - Diluted	-32.16	-21.9	-12.86	-1.34	-0.16
Diluted EPS - Continuing Operations	-32.16	-21.9	-12.86	-1.34	-0.16
Diluted Weighted Average Shares Outstanding	324K	660K	1.18M	5.02M	35.98M
Normalized Basic EPS	-20.96	-13.96	-8.21	-0.87	-0.1
Normalized Diluted EPS	-20.96	-13.96	-8.21	-0.87	-0.1
Supplemental Items
EBITDA	-5.81M	-13.44M	-11.99M	-5.59M	-5.24M
EBITA	-5.82M	-13.46M	-12.01M	-5.62M	-5.26M
EBIT	-5.82M	-13.46M	-12.01M	-5.62M	-5.26M
EBITDAR	-5.8M	-13.44M	-11.99M	-5.59M	-
Effective Tax Rate - (Ratio)	-	-0.01	-0.05	-0.03	-
Current Domestic Taxes	-	1K	7K	2K	-
Total Current Taxes	-	1K	7K	2K	-
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	-6.78M	-9.21M	-9.65M	-4.36M	-3.58M
Interest on Long-Term Debt	126K	49K	133K	17K	18K
Supplemental Operating Expense Items
General and Administrative Expenses	1.88M	2.88M	3.88M	2.99M	2.98M
Research And Development Expense From Footnotes	4.02M	10.66M	8.15M	2.65M	2.3M
Net Rental Expense, Total	2K	2K	3K	6K	-
Imputed Operating Lease Interest Expense	407	507	978	311	-
Imputed Operating Lease Depreciation	1.59K	1.49K	2.02K	5.69K	-
Maintenance & Repair Expenses, Total	-	-	-	-	-
Stock-Based Comp., R&D Exp. (Total)	51K	166K	201K	123K	86K
Stock-Based Comp., G&A Exp. (Total)	111K	309K	388K	273K	226K
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	162K	475K	589K	396K	312K

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	10.3M	9.46M	4.63M	2.24M	3.24M
Total Cash And Short Term Investments	10.3M	9.46M	4.63M	2.24M	3.24M
Accounts Receivable, Total	-	-	-	-	-
Other Receivables	69K	81K	279K	41K	26K
Total Receivables	69K	81K	279K	41K	26K
Inventory	-	-	-	-	-
Prepaid Expenses	94K	98K	62K	79K	68K
Restricted Cash	27K	26K	12K	12K	10K
Other Current Assets, Total	33K	32K	24K	9K	19K
Total Current Assets	10.53M	9.69M	5.01M	2.39M	3.36M
Gross Property Plant And Equipment	414K	380K	522K	418K	324K
Accumulated Depreciation	-296K	-314K	-301K	-322K	-290K
Net Property Plant And Equipment	118K	66K	221K	96K	34K
Long-term Investments	5K	-	-	-	5K
Other Intangibles, Total	4K	4K	4K	4K	4K
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	-	5K	5K	5K	-
Total Assets	10.65M	9.77M	5.24M	2.49M	3.41M
Liabilities
Accounts Payable, Total	1.8M	2.24M	1.7M	1.17M	1.33M
Accrued Expenses, Total	427K	478K	482K	334K	403K
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	2.42M	3.91M	1.1M	-
Current Portion of Leases	48K	21K	112K	66K	-
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	619K	113K	250K	118K	63K
Total Current Liabilities	2.9M	5.27M	6.45M	2.78M	1.79M
Long-Term Debt	38K	-	-	-	-
Long-Term Leases	21K	-	67K	-	-
Unearned Revenue Non Current	-	-	-	-	-
Total Liabilities	2.96M	5.27M	6.51M	2.78M	1.79M
Common Stock, Total	472K	746K	1.74M	173K	942K
Additional Paid In Capital	165M	176M	185M	194M	201M
Retained Earnings	-158M	-173M	-188M	-194M	-200M
Treasury Stock	-193K	-194K	-223K	-224K	-226K
Comprehensive Income and Other	-	5K	8K	6K	10K
Total Common Equity	7.71M	4.52M	-1.27M	-294K	1.61M
Minority Interest	-12K	-13K	-	-	-
Total Equity	7.7M	4.5M	-1.27M	-294K	1.61M
Total Liabilities And Equity	10.65M	9.77M	5.24M	2.49M	3.41M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	471K	842K	1.72M	17.28M	94.11M
ECS Total Common Shares Outstanding	471K	745K	1.72M	17.28M	94.11M
Book Value / Share	16.37	6.06	-0.74	-0.02	0.02
Tangible Book Value	7.71M	4.51M	-1.28M	-298K	1.61M
Tangible Book Value Per Share	16.36	6.05	-0.74	-0.02	0.02
Total Debt	107K	2.44M	4.09M	1.17M	0
Net Debt	-10.2M	-7.02M	-548K	-1.08M	-3.24M
Debt Equivalent Oper. Leases	16K	16K	24K	48K	-
Minority Interest, Total (Incl. Fin. Div)	-12K	-13K	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	348K	361K	348K	357K	324K
Full Time Employees	12	13	13	13	12

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-10.4M	-14.45M	-15.13M	-6.74M	-5.72M
Depreciation & Amortization - CF	63K	66K	92K	144K	78K
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	63K	66K	92K	144K	78K
Amortization of Deferred Charges, Total - (CF)	-	47K	122K	4K	-
(Gain) Loss From Sale Of Asset	-	-	-	-	-
Stock-Based Compensation (CF)	162K	475K	589K	396K	312K
Other Operating Activities, Total	4.59M	1.08M	2.91M	1.11M	481K
Change In Accounts Receivable	-	-	-	-	-
Change In Inventories	-	-	-	-	-
Change In Accounts Payable	390K	421K	-580K	-791K	194K
Change In Income Taxes	-	-	-	-	-
Change In Deferred Taxes	-	-	-	-	-
Change in Other Net Operating Assets	-27K	-14K	-140K	236K	23K
Cash from Operations	-5.22M	-12.38M	-12.14M	-5.64M	-4.63M
Capital Expenditure	-39K	-14K	-21K	-19K	-16K
Sale of Property, Plant, and Equipment	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	0	-	-	-	-5K
Cash from Investing	-39K	-14K	-21K	-19K	-21K
Long-Term Debt Issued, Total	5.74M	4.37M	7.43M	1M	-
Total Debt Issued	5.74M	4.37M	7.43M	1M	-
Long-Term Debt Repaid, Total	-55K	-25K	-57K	-1.04M	-1.22M
Total Debt Repaid	-55K	-25K	-57K	-1.04M	-1.22M
Issuance of Common Stock	8.8M	7.22M	85K	3.17M	7.28M
Repurchase of Common Stock	-4K	-1K	-29K	-1K	-2K
Other Financing Activities, Total	-299K	-66K	-145K	140K	-400K
Cash from Financing	14.18M	11.5M	7.28M	3.27M	5.66M
Foreign Exchange Rate Adjustments	-	49K	57K	-1K	-10K
Net Change in Cash	8.92M	-848K	-4.82M	-2.39M	995K
Supplemental Items
Cash Interest Paid	3K	2K	11K	13K	2K
Cash Income Tax Paid (Refund)	-	-	-	6K	-
Levered Free Cash Flow	-4.09M	-7.36M	-7.35M	-3.57M	-2.73M
Unlevered Free Cash Flow	-4.09M	-7.38M	-7.39M	-3.57M	-2.72M
Change In Net Working Capital	635K	-509K	539K	572K	-191K
Net Debt Issued / Repaid	5.69M	4.35M	7.37M	-39K	-1.22M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-58.78	-82.39	-100.06	-90.92	-111.45
Return on Total Capital	-119.74	-110.03	-153.93	-190.72	-264.38
Return On Equity %	-356.13	-236.93	-937.03	860.28	-866.97
Return on Common Equity	-354.7	-236.43	-933.21	860.28	-866.97
Margin Analysis
Gross Profit Margin %	100	100	-	-	-
SG&A Margin	5.37K	8.72K	-	-	-
EBITDA Margin %	-16.59K	-40.73K	-	-	-
EBITA Margin %	-16.64K	-40.79K	-	-	-
EBIT Margin %	-16.64K	-40.79K	-	-	-
Income From Continuing Operations Margin %	-29.73K	-43.8K	-	-	-
Net Income Margin %	-29.73K	-43.79K	-	-	-
Net Avail. For Common Margin %	-29.73K	-43.79K	-	-	-
Normalized Net Income Margin	-19.38K	-27.92K	-	-	-
Levered Free Cash Flow Margin	-11.69K	-22.31K	-	-	-
Unlevered Free Cash Flow Margin	-11.68K	-22.35K	-	-	-
Asset Turnover
Asset Turnover	0.01	0	-	-	-
Fixed Assets Turnover	0.27	0.36	-	-	-
Inventory Turnover (Average Inventory)	-	-	-	-	-
Short Term Liquidity
Current Ratio	3.63	1.84	0.78	0.86	1.88
Quick Ratio	3.58	1.81	0.76	0.82	1.82
Operating Cash Flow to Current Liabilities	-1.8	-2.35	-1.88	-2.02	-2.59
Days Outstanding Inventory (Average Inventory)	-	-	-	-	-
Average Days Payable Outstanding	-	-	-	-	-
Long Term Solvency
Total Debt/Equity	1.39	54.2	-321.23	-396.6	-
Total Debt / Total Capital	1.37	35.15	145.2	133.72	-
LT Debt/Equity	0.77	-	-5.27	-	-
Long-Term Debt / Total Capital	0.76	-	2.38	-	-
Total Liabilities / Total Assets	27.75	53.91	124.27	111.8	52.61
EBIT / Interest Expense	-1.94K	-274.71	-90.33	-330.82	-292.11
EBITDA / Interest Expense	-1.92K	-273.37	-89.64	-322.35	-287.78
(EBITDA - Capex) / Interest Expense	-1.93K	-273.65	-89.8	-323.47	-288.67
Total Debt / EBITDA	-0.02	-0.18	-0.34	-0.21	-
Net Debt / EBITDA	1.77	0.52	0.05	0.2	0.63
Total Debt / (EBITDA - Capex)	-0.02	-0.18	-0.34	-0.21	-
Net Debt / (EBITDA - Capex)	1.76	0.52	0.05	0.2	0.62
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-77.27	-5.71	-	-	-
Gross Profit, 1 Yr. Growth %	-77.27	-5.71	-	-	-
EBITDA, 1 Yr. Growth %	43.6	131.48	-10.78	-53.36	-6.29
EBITA, 1 Yr. Growth %	43.31	131.13	-10.75	-53.19	-6.51
EBIT, 1 Yr. Growth %	43.31	131.13	-10.75	-53.19	-6.51
Earnings From Cont. Operations, 1 Yr. Growth %	1.11K	38.89	4.7	-55.49	-15.05
Net Income, 1 Yr. Growth %	1.11K	38.89	4.71	-55.49	-15.05
Normalized Net Income, 1 Yr. Growth %	1.01K	35.82	4.78	-54.87	-17.92
Diluted EPS Before Extra, 1 Yr. Growth %	316.72	-31.89	-41.27	-89.57	-88.15
Inventory, 1 Yr. Growth %	-	-	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	-16.9	-44.07	234.85	-56.56	-64.58
Total Assets, 1 Yr. Growth %	515.13	-8.32	-46.35	-52.47	36.73
Tangible Book Value, 1 Yr. Growth %	-517.22	-41.46	-128.29	-76.65	-640.27
Common Equity, 1 Yr. Growth %	-518.34	-41.44	-128.17	-76.89	-648.98
Cash From Operations, 1 Yr. Growth %	21.89	137	-1.92	-53.59	-17.76
Capital Expenditures, 1 Yr. Growth %	143.75	-64.1	50	-9.52	-15.79
Levered Free Cash Flow, 1 Yr. Growth %	-31.78	60.34	-0.16	-51.39	-23.52
Unlevered Free Cash Flow, 1 Yr. Growth %	-31.79	59.16	0.14	-51.73	-23.69
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-53.71	-	-	-
Gross Profit, 2 Yr. CAGR %	-	-53.71	-	-	-
EBITDA, 2 Yr. CAGR %	12.44	82.32	43.71	-35.5	-33.89
EBITA, 2 Yr. CAGR %	12.33	82	43.63	-35.36	-33.84
EBIT, 2 Yr. CAGR %	12.33	82	43.63	-35.36	-33.84
Earnings From Cont. Operations, 2 Yr. CAGR %	-1.56	309.71	20.59	-31.73	-38.51
Net Income, 2 Yr. CAGR %	-1.54	309.7	20.59	-31.73	-38.51
Normalized Net Income, 2 Yr. CAGR %	2.48	288.04	19.29	-31.23	-39.13
Diluted EPS Before Extra, 2 Yr. CAGR %	-65.47	68.48	-36.75	-75.24	-88.88
Net Property, Plant and Equip., 2 Yr. CAGR %	89.1	-31.82	36.85	20.6	-60.78
Total Assets, 2 Yr. CAGR %	53.56	137.48	-29.86	-49.5	-19.39
Tangible Book Value, 2 Yr. CAGR %	72.13	56.28	-59.31	-74.3	12.33
Common Equity, 2 Yr. CAGR %	72.34	56.52	-59.38	-74.48	12.64
Cash From Operations, 2 Yr. CAGR %	14.28	69.96	52.46	-32.54	-38.22
Capital Expenditures, 2 Yr. CAGR %	108.17	-6.46	-26.62	16.5	-12.71
Levered Free Cash Flow, 2 Yr. CAGR %	32.09	10.79	26.52	-30.33	-39.02
Unlevered Free Cash Flow, 2 Yr. CAGR %	30.91	10.93	26.25	-30.47	-39.31
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-46.92	-	-	-	-
Gross Profit, 3 Yr. CAGR %	-46.92	-	-	-	-
EBITDA, 3 Yr. CAGR %	7.24	43.04	43.67	-1.24	-26.94
EBITA, 3 Yr. CAGR %	7.19	42.87	43.52	-1.16	-26.9
EBIT, 3 Yr. CAGR %	7.12	42.87	43.52	-1.16	-26.9
Earnings From Cont. Operations, 3 Yr. CAGR %	24.52	10.41	160	-13.5	-26.57
Net Income, 3 Yr. CAGR %	24.55	10.42	159.99	-13.49	-26.57
Normalized Net Income, 3 Yr. CAGR %	23.23	12.57	150.81	-13.72	-27.05
Diluted EPS Before Extra, 3 Yr. CAGR %	-49.76	-56.7	18.57	-65.31	-80.64
Net Property, Plant and Equip., 3 Yr. CAGR %	35.91	25.99	15.89	-6.65	-19.84
Total Assets, 3 Yr. CAGR %	125.51	29.31	44.64	-38.39	-29.62
Tangible Book Value, 3 Yr. CAGR %	25.3	20.15	-11.6	-66.18	-29.07
Common Equity, 3 Yr. CAGR %	25.38	20.26	-11.63	-66.34	-29.03
Cash From Operations, 3 Yr. CAGR %	7.23	45.74	41.5	2.56	-27.93
Capital Expenditures, 3 Yr. CAGR %	169.16	15.87	9.49	-21.31	4.55
Levered Free Cash Flow, 3 Yr. CAGR %	6.05	46.43	7.01	-8.02	-28.13
Unlevered Free Cash Flow, 3 Yr. CAGR %	19.75	45.68	7.21	-8.37	-28.28
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-4.03	-41.26	-	-	-
Gross Profit, 5 Yr. CAGR %	-26.66	-36.4	-	-	-
EBITDA, 5 Yr. CAGR %	-16.27	10.24	20.56	4.02	5.32
EBITA, 5 Yr. CAGR %	-16.43	9.92	20.5	4.03	5.29
EBIT, 5 Yr. CAGR %	-16.47	9.84	20.45	4.03	5.29
Earnings From Cont. Operations, 5 Yr. CAGR %	-8.36	6.09	22.93	-8.9	46.05
Net Income, 5 Yr. CAGR %	-8.36	6.1	22.95	-8.9	46.05
Normalized Net Income, 5 Yr. CAGR %	-7.02	6.98	21.64	-7.57	42.35
Diluted EPS Before Extra, 5 Yr. CAGR %	-53.49	-49.56	-44.91	-65.38	-53.99
Net Property, Plant and Equip., 5 Yr. CAGR %	-27.84	-0.3	36.29	23.81	-24.87
Total Assets, 5 Yr. CAGR %	12.02	27.77	41.34	-11.23	14.48
Tangible Book Value, 5 Yr. CAGR %	1.71	12.58	-20.09	-35.16	-2.71
Common Equity, 5 Yr. CAGR %	1.86	12.73	-20.12	-35.31	-2.62
Cash From Operations, 5 Yr. CAGR %	-17.27	6.61	23.44	7.09	1.57
Capital Expenditures, 5 Yr. CAGR %	37.28	-7.79	60.04	16.12	0
Levered Free Cash Flow, 5 Yr. CAGR %	-14.26	-0.47	16.46	8.79	-14.55
Unlevered Free Cash Flow, 5 Yr. CAGR %	-12.6	3.52	25.41	8.37	-14.61